Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
Millions across all 50 US states march in No Kings protests against Trump
19/10/2025
Government aims to create 400,000 jobs through UK national green energy plan
19/10/2025
The moment I knew : she made the life I’d overcomplicated suddenly straightforward
18/10/2025
‘I lost 25 pounds in 20 days’ : what it’s like to be on the frontline of a global cyber-attack
18/10/2025
Techno-capitalists think innovation can save the planet. But that same thinking is what got us here
18/10/2025
Giant review – Prince Naseem biopic with Pierce Brosnan on hand misses the punch
18/10/2025